Status:
ENROLLING_BY_INVITATION
Belgian Cross-sectional Allogeneic Transplant Survivor Study
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation, Allogeneic
Eligibility:
All Genders
18-100 years
Brief Summary
With the increasing successful use of allogeneic hematopoietic stem cell transplantation (HSCT) to cure advanced hematological disease, it becomes essential to evaluate the long-term effects of such a...
Detailed Description
This is a cross sectional study, where participants are interviewed and fill in a self reported survey. The interview and survey are only taken once. It is non interventional because the patients only...
Eligibility Criteria
Inclusion
- Ability to read and write in Dutch
- Age above 18 years at time of transplant
- Transplanted in UZ Leuven between 1992 and 2012 with an allogeneic donor (i.e. being at least 2 years post-Tx)
- Presenting for a periodic health check in UZLEUVEN from November 15th, 2014 to November 15th 2016
- Willing to provide oral and written consent
Exclusion
- Unable to communicate fluently in Dutch
- Presenting with major visual, hearing, cognitive or psychiatric conditions precluding participation
- Presenting with relapse or other major illness, with less than 6 months expected survival
- Hospitalized for a life-threatening condition
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT02312830
Start Date
November 1 2014
End Date
November 1 2025
Last Update
July 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.